EVOLUS, INC. Payments of Debt Issuance Costs
EVOLUS, INC. (EOLS) reported Payments of Debt Issuance Costs of $609.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-05
- EVOLUS, INC. payments of debt issuance costs for the quarter ending 2026-06-30 was $125.00K, a 95.21% decline year-over-year.
- EVOLUS, INC. payments of debt issuance costs for the quarter ending 2026-03-31 was $484.00K.
- EVOLUS, INC. payments of debt issuance costs for the quarter ending 2025-06-30 was $2.61M.
- EVOLUS, INC. payments of debt issuance costs for the quarter ending 2025-03-31 was $0.00.
- EVOLUS, INC. payments of debt issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EVOLUS, INC. payments of debt issuance costs for fiscal 2023 was $46.00K, a 90.80% decline from fiscal 2022.
- EVOLUS, INC. payments of debt issuance costs for fiscal 2022 was $500.00K, a 84.68% decline from fiscal 2021.
- EVOLUS, INC. payments of debt issuance costs for fiscal 2021 was $3.26M.
| Period end | Payments of Debt Issuance Costs | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $609.00K 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $484.00K 10-Q · filed 2026-05-04 | ||||
| 2025-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.61M 10-Q · filed 2026-08-05 | $2.61M derived: sum of 3 quarters · filed 2026-08-05 | $2.61M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $0.00 derived: sum of 2 quarters · filed 2025-03-04 | $0.00 10-K · filed 2025-03-04 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-07-31 | ||||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $8.00K derived: sum of 2 quarters · filed 2025-03-04 | $46.00K 10-K · filed 2025-03-04 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $38.00K 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $38.00K 10-Q · filed 2024-07-31 | ||||
| 2022-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $500.00K derived: sum of 2 quarters · filed 2025-03-04 | $500.00K 10-K · filed 2025-03-04 | ||
| 2022-12-05 | $500.00K 10-Q · filed 2023-05-09 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | ||||
| 2021-12-31 | $3.26M 10-K · filed 2023-03-08 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $0.00 derived: sum of 3 quarters · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $2.21M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $2.21M 10-Q · filed 2020-10-29 | $2.21M derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.21M 10-Q · filed 2020-08-10 | $2.21M derived: sum of 3 quarters · filed 2020-08-10 | $2.21M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $2.21M 10-Q · filed 2020-05-11 | $2.21M derived: sum of 2 quarters · filed 2020-05-11 | $2.21M derived: sum of 3 quarters · filed 2020-05-11 | $2.21M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |